Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas Bernd Dschietzig
Thomas Bernd Dschietzig
Relaxin
Endocrinology
Clinical trial
Glucocorticoid receptor
Heart failure with preserved ejection fraction
2
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Custodiol® Supplemented with Synthetic Human Relaxin Decreases Ischemia-Reperfusion Injury after Porcine Kidney Transplantation.
2021
International Journal of Molecular Sciences
Augustinas Bausys
Juste Maneikyte
Bettina Leber
Jennifer Weber
Nicole Feldbacher
Kęstutis Strupas
Thomas Bernd Dschietzig
Peter Schemmer
Philipp Stiegler
Show All
Source
Cite
Save
Citations (0)
Relaxin-2 for heart failure with preserved ejection fraction (HFpEF): Rationale for future clinical trials
2019
Molecular and Cellular Endocrinology
Thomas Bernd Dschietzig
Show All
Source
Cite
Save
Citations (8)
1